Finding Canadian cancer clinical trials on the Internet: An exploratory evaluation of online resources

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 9, 2003, Pages 1127-1129

  Till, James E ^b   Phillips, Robert A ^b   Jadad, Alejandro R ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANADA; CANCER CENTER; CANCER RESEARCH; CLINICAL TRIAL; DATA BASE; HUMAN; INTERNET; MEDICAL INFORMATION; MEDICAL SOCIETY; MEDLINE; ONLINE SYSTEM; UNITED STATES;

EID: 0037738771     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fisher B. On clinical trial participation. J Clin Oncol 1991;9:1927-30.
2. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: Understanding and attitudes predict willingness to participate. J Clin Oncol 2001;19:3554-61.
3. Gotay CC. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med 1991;33:569-77.
4. Sutherland HJ, Carlin K, Harper W, Martin LJ, Greenberg CV, Till JE, et al. A study of diet and breast cancer prevention in Canada: why healthy women participate in controlled trials. Cancer Causes Control 1993;4:521-8.
5. Richardson MA, Post-White J, Singletary SE, Justice B. Recruitment for complementary/alternative medicine trials: who participates after breast cancer. Ann Behav Med 1998;20:190-8.
6. Rogers EM. Diffusion of innovations. 4th ed. New York: Free Press; 1995.
7. Norman DA. Growing up: moving from technology-centered to human-centered products. In: The invisible computer. Cambridge: MIT Press; 1998. Available: mitpress.mit.edu/books/NORVH/chapter2.html (accessed 2003 Mar 31).
8. McCray AT, Ide NC. Design and implementation of a national clinical trials registry. J Am Med Inform Assoc 2000;7(3):313-23.
9. Manheimer E, Anderson D. Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility. BMJ 2002;325:528-31.
10. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev 1997;9(Suppl A):15-21.
11. Guidance for industry: information program on clinical trials for serious or life-threatening diseases and conditions. Washington: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research; 2002. Available: www.fda.gov/cder/guidance/4856fnl.htm (accessed 2003 Mar 31).
12. Eysenbach G, Jadad AR. Evidence-based patient choice and consumer health informatics in the Internet age. J Med Internet Res 2001;3(2):e19. Available: www.jmir.org/2001/2/e19 (accessed 2003 Mar 31).
13. Rehnquist J. Clinical trial Web sites: a promising tool to foster informed consent. Washington: Office of the Inspector General, US Department of Health and Human Services; 2002. Publ no OEI-01-97-00198. Available (PDF format): http://oig.hhs.gov/oei/reports/oei-01-97-00198.pdf (accessed 2003 Mar 31).
14. Jadad AR. Promoting partnerships: challenges for the Internet age. BMJ 1999;319:761-4. Available: www.bmj.com/cgi/content/full/319/7212/761 (accessed 2003 Mar 31).
15. Jadad AR, Enkin MW. The new alchemy: transmuting information to knowledge in the electronic age [editorial]. CMAJ 2000;162(13):1826-8.